Free Trial

Brokerages Set Avantor, Inc. (NYSE:AVTR) PT at $25.50

Avantor logo with Medical background
Remove Ads

Shares of Avantor, Inc. (NYSE:AVTR - Get Free Report) have been given a consensus rating of "Moderate Buy" by the twelve research firms that are covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $25.50.

AVTR has been the topic of a number of recent analyst reports. Wells Fargo & Company cut their price target on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a report on Monday, February 10th. Royal Bank of Canada lowered their price objective on shares of Avantor from $33.00 to $31.00 and set an "outperform" rating for the company in a research report on Monday, February 10th. UBS Group reissued a "neutral" rating and set a $25.00 target price (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Barclays reduced their price objective on shares of Avantor from $26.00 to $23.00 and set an "overweight" rating for the company in a research report on Monday, February 10th. Finally, Morgan Stanley lowered their target price on shares of Avantor from $27.00 to $25.00 and set an "overweight" rating for the company in a research note on Monday, February 10th.

Check Out Our Latest Stock Analysis on Avantor

Insider Buying and Selling

In other Avantor news, EVP James Bramwell sold 3,758 shares of the company's stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the transaction, the executive vice president now owns 87,379 shares in the company, valued at approximately $1,531,753.87. This represents a 4.12 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Steven W. Eck sold 4,907 shares of the company's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the sale, the chief accounting officer now owns 40,604 shares of the company's stock, valued at $711,788.12. This trade represents a 10.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by corporate insiders.

Remove Ads

Institutional Trading of Avantor

Several hedge funds have recently made changes to their positions in AVTR. MassMutual Private Wealth & Trust FSB lifted its position in Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock valued at $26,000 after buying an additional 625 shares in the last quarter. Smartleaf Asset Management LLC boosted its holdings in shares of Avantor by 106.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock worth $34,000 after buying an additional 830 shares during the period. Global Retirement Partners LLC lifted its position in shares of Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock worth $52,000 after purchasing an additional 1,067 shares in the last quarter. UMB Bank n.a. raised its position in Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock valued at $63,000 after acquiring an additional 1,074 shares in the last quarter. Finally, AlphaQuest LLC acquired a new stake in shares of Avantor in the fourth quarter worth $65,000. Institutional investors and hedge funds own 95.08% of the company's stock.

Avantor Trading Up 3.3 %

Shares of AVTR stock traded up $0.52 during mid-day trading on Tuesday, reaching $16.34. 5,096,664 shares of the stock traded hands, compared to its average volume of 6,220,613. The stock's fifty day simple moving average is $19.62 and its two-hundred day simple moving average is $22.12. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54. The company has a market cap of $11.12 billion, a price-to-earnings ratio of 15.71, a price-to-earnings-growth ratio of 1.55 and a beta of 1.30. Avantor has a 1-year low of $15.37 and a 1-year high of $28.00.

Avantor (NYSE:AVTR - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same period in the previous year, the company earned $0.22 EPS. On average, research analysts anticipate that Avantor will post 1.06 EPS for the current fiscal year.

About Avantor

(Get Free Report

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Read More

Analyst Recommendations for Avantor (NYSE:AVTR)

Should You Invest $1,000 in Avantor Right Now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads